Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-26-212447
Filing Date
2026-05-07
Accepted
2026-05-07 17:21:03
Documents
4
Effectiveness Date
2026-05-07

Document Format Files

Seq Description Document Type Size
1 S-8 POS d113246ds8pos.htm S-8 POS 48405
2 EX-5.1 d113246dex51.htm EX-5.1 10044
3 EX-23.1 d113246dex231.htm EX-23.1 2097
4 GRAPHIC g113246g0507053925206.jpg GRAPHIC 3475
  Complete submission text file 0001193125-26-212447.txt   66709
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

EIN.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-276614 | Film No.: 26954924
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)